Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20619739 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer
Condition: Metastatic Colo-rectal Cancer
Intervention: Drug: FOLFOXIRI + Panitumumab

Indicates status has not been verified in more than two years